![]() Storm Therapeutics Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. | ![]() Cambridge Epigenetix Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw. | ||
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2012 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations Norwich, GB HQ Norwich, GB | Locations Cambridge, GB HQ Greater London, GB | Locations Little Chesterford, GB HQ Wilmslow, GB |
Employees | Employees 572% decrease | Employees 327% increase | Employees 1121% decrease |
Funding | |||
Latest funding round | Latest funding round $ 1.4m (over 7 years ago) | Latest funding round $ 5.4m (over 8 years ago) | Latest funding round $ 30m (about 8 years ago) |
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 21.4m | Total funding raised $ 56.5m |

Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer.
View company
Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
View company